NovaBay Pharma Schedules Special Shareholder Meeting on Warrants

NovaBay Pharma ( (NBY) ) has provided an announcement.

NovaBay Pharmaceuticals, Inc. scheduled a special meeting of stockholders for March 12, 2026, at 11:00 a.m. Eastern Time to consider key corporate actions. At the meeting, investors were set to vote on proposals to approve the issuance of common stock upon exercise of pre-funded warrants that had been issued in private placement transactions on October 16, 2025, and January 16, 2026, a step that could impact the company’s capital structure and shareholder base.

The most recent analyst rating on (NBY) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on NovaBay Pharma stock, see the NBY Stock Forecast page.

Spark’s Take on NBY Stock

According to Spark, TipRanks’ AI Analyst, NBY is a Neutral.

The score is primarily held down by weak financial performance (shrinking revenue, very large operating losses, and heavy cash burn). Technicals add near-term weakness with the stock below key short-term moving averages and low momentum readings. Valuation is difficult to assess favorably due to a negative P/E and no dividend, while recent financing-related corporate events raise dilution and strategic risk despite improving access to capital.

To see Spark’s full report on NBY stock, click here.

More about NovaBay Pharma

Average Trading Volume: 1,618,539

Technical Sentiment Signal: Sell

Current Market Cap: $252.3M

For a thorough assessment of NBY stock, go to TipRanks’ Stock Analysis page.